Moore Paul Andrew
Reporting owner on Forms 3, 4 and 5, CIK 1938192.
Moore Paul Andrew reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-11-16.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| ZYME · Zymeworks Inc.CIK 1937653 | officer (Chief Scientific Officer) | 1 | 2026-11-16 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| ZYME · Zymeworks Inc.Common Stock | 2026-11-13 | M exercised | +25,000 | $5.82 | 73,497 | Form 4 |
| ZYME · Zymeworks Inc.Common Stock | 2026-11-13 | S sold | -7,367 | $26.14 | 66,130 | Form 4 |
| ZYME · Zymeworks Inc.Common Stock | 2026-11-13 | S sold | -7,374 | $26.09 | 58,756 | Form 4 |
| ZYME · Zymeworks Inc.Common Stock | 2026-11-13 | S sold | -25,000 | $26.04 | 33,756 | Form 4 |
| ZYME · Zymeworks Inc.Stock Option (Right to Buy), derivative | 2026-11-13 | M exercised | -25,000 | $0 | 175,000 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001938192-26-000007 | Zymeworks Inc. | 2026-11-16 |